There are likely to be hundreds of monogenic forms of human male infertility. Whole genome sequencing (WGS) is the most efficient way to make progress in mapping the causative genetic variants, and ultimately improve clinical management of the disease in each patient. Recruitment of consanguineous families is an effective approach to ascertain the genetic forms of many diseases.
To apply WGS to large consanguineous families with likely hereditary male infertility and identify potential genetic cases.
We recruited seven large families with clinically diagnosed male infertility from rural Pakistan, including five with a history of consanguinity. We generated WGS data on 26 individuals (3-5 per family) and analyzed the resulting data with a computational pipeline to identify potentially causal single nucleotide variants, indels, and copy number variants.
We identified plausible genetic causes in five of the seven families, including a homozygous 10 kb deletion of exon 2 in a well-established male infertility gene (M1AP), and biallelic missense substitutions (SPAG6, CCDC9, TUBA3C) and an in-frame hemizygous deletion (TKTL1) in genes with emerging relevance.
The rate of genetic findings using the current approach (71%) was much higher than what we recently achieved using whole-exome sequencing (WES) of unrelated singleton cases (20%). Furthermore, we identified a pathogenic single-exon deletion in M1AP that would be undetectable by WES. Screening more families with WGS, especially in underrepresented populations, will further reveal the types of variants underlying male infertility and accelerate the use of genetics in the patient management.
Andrology. 2023 Dec 10 [Epub ahead of print]
Muhammad Riaz Khan, Arvand Akbari, Thomas J Nicholas, Helen Castillo-Madeen, Muhammad Ajmal, Taqweem Ul Haq, Maris Laan, Aaron R Quinlan, Jasvinder S Ahuja, Aftab Ali Shah, Donald F Conrad
Department of Biotechnology, Faculty of Biological Sciences, University of Malakand, Chakdara, Khyber Pakhtunkhwa, Pakistan., Center for Embryonic Cell & Gene Therapy, Oregon Health & Science University, Portland, Oregon, USA., Department of Human Genetics, University of Utah, Salt Lake City, Utah, USA., Chair of Human Genetics, Institute of Biomedicine and Translational Medicine, University of Tartu, Tartu, Estonia.